The goal of this paper is to clarify how entrepreneurs, investors, and regulatory agencies influence the value of emerging health technologies.
Lehoux, P., Miller, F.A., Daudelin, G., Denis, J.L. (2017). Providing value to new health technology: the early contribution of entrepreneurs, investors, and regulatory agencies, International Journal of Health Policy and Management.
This article seeks to deepen our understanding of the responsible research and innovation (RRI) approach as it relates to health care systems, where the notion of responsibility is already deeply embedded.
Demers-Payette, O., Lehoux, P., Daudelin, G. (2016). Responsible research and innovation: a productive model for the future of medical innovation, Journal of Responsible Innovation.
This article aims to generate a better understanding of the historical Research & Development dynamics that have contributed to shape today’s medical innovation ecosystem.
Lehoux, P., Roncarolo, F., Rocha Oliveira, R., Silva, H.P. (2016). Medical innovation and the sustainability of health systems: A historical perspective on technological change in health, Health Services Management Research.
This article looks at a prospective method using multimedia material for public deliberations on health technology design.
Lehoux, P., Jimenez-Pernett, J., Miller, F. A., Williams-Jones, B. (2016). Assessment of a multimedia-based prospective method to support public deliberations on health technology design: participant survey findings and qualitative insights, BMC Health Services Research.
This paper brings forward why capital investors choose to invest in certain health technology-based ventures and not others, and how they influence the innovation process.
Lehoux, P., Miller, F.A., Daudelin, G., Urbach, D.R. (2015). How venture capitalists decide which new medical technologies come to exist, Science & Public Policy.
We regularly organize high-impact knowledge mobilization activities
Our team in action
Jaime completed his PhD thesis on ways to account for asymmetries in public deliberation mechanisms. Holding a master degree in applied economics (Toulouse, France), he is a teaching and research assistant at the Andalusian School of Public Health (EASP) in Spain. His research interests include digital technologies and social networks analysis.
Hudson P. Silva is an economist and was Assistant Professor in Public Policy and Management at the State University of Campinas. His research activities are in public policy analysis, focusing on social protection, public health and health technology management. He holds practical experience as a technical advisor for the Brazilian Ministry of Health and the State Government of Sao Paulo.
Xavier Pavie (ESSEC Business School) is a philosopher and management scholar. He has spent 15 years as Marketing Director in leading organizations. He is the Director of the Institute for Strategic Innovation & Services and Chairs the Imagination Week seminar for ESSEC’s 600 Master students. He leads the responsible innovation definition efforts of an international network of academic institutions supported by the European Commission. He is President of the “Innovation-Regulation-Governance” commission of the French National Agency for Research as part of Horizon 2020.